Paroxetine Related Compound F CAS 110429-36-2
| CAS No. | 110429-36-2 |
| Molecular Formula | C20H22FNO3 |
| Molecular Weight | 343.39 g/mol |
| Category | Pharmaceutical Standards / API Standards |
| Availability | In Stock |
Chemical Structure
Description
Structurally, Paroxetine Related Compound F (C20H22FNO3) contains a steroid core, an amide group, a hydroxyl group, an ether linkage, fluorine substitution. The molecule exhibits a degree of unsaturation (DBE) of 10.0, corresponding to approximately 10 ring(s) or double-bond equivalent(s). With a molecular weight of 343.39 g/mol, it falls into the moderately-high-molecular-weight range. The presence of an aromatic ring or conjugated system gives the compound characteristic absorption bands in the UV-Vis region, making it well suited to UV or diode-array detection (DAD).
CATO supplies Paroxetine Related Compound F (CAS 110429-36-2), a certified reference material (molecular formula C20H22FNO3, MW 343.39 g/mol) for analytical method development and quality control.
This reference standard is suitable for quantitative analysis on major chromatographic platforms including HPLC, GC, LC-MS/MS, and GC-MS, serving as an external calibration standard or a system suitability test reference material.
As a certified reference material (CRM), Paroxetine Related Compound F meets the metrological traceability requirements of ISO/IEC 17025 laboratories. Batch-to-batch consistency is monitored via control charts to guarantee comparable assigned values across lots.
Physical & Chemical Properties
| Molecular Formula | C20H22FNO3 |
| Molecular Weight | 343.39 g/mol |
| Appearance | Pale yellow to yellow crystalline powder. (slight halide-like odor) |
| Purity | >95% |
| Storage | Store at 2-8°C, protect from light, keep sealed and dry |
| Solubility (reference) | Soluble in chloroform, dichloromethane, ethyl acetate, DMSO |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Contains ester bond; hydrolyzes under strong alkaline conditions |
| Degree of Unsaturation (DBE) | 10.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| CAS Registry Year (est.) | 1988 |
| Halogen Content | F-containing |
| Nitrogen Atoms | 1 |
Related Paroxetine Standards
- Paroxetine Impurity 27 (CAS 2575750-19-3)
- Paroxetine Impurity 28 (CAS CATO-C4X-103528)
- Paroxetine 3-Hydroxy Metabolite (CAS 112058-89-6)
- Paroxetine 4-Hydroxy Metabolite (CAS 112058-90-9)
- Paroxetine Hydrochloride Hemihydrate - Impurity C (Freebase) (CAS 1395408-54-4)
- Paroxetine Impurity 70 (CAS 1396174-70-1)
- Paroxetine (CAS 61869-08-7)
- Paroxetine Impurity 64 (CAS 2361294-43-9)
Recommended Standards
- Citalopram EP Impurity M (CAS 440121-09-5)
- Escitalopram EP Impurity M (CAS 1881237-26-8)
- Methyl 3-(N-(3-fluorobenzyl)methylsulfonamido)thiophene-2-carboxylate (CAS 892283-38-4)
- Fudosteine Impurity 53 (CAS CATO-C4X-144753)
- (4-Ethyl-2-methoxyphenyl)hydrazine (CAS 1804291-27-7)
- 1-tert-Butyl 3-methyl 3-ethylazetidine-1,3-dicarboxylate (CAS 1262410-80-9)
- 2-fluoro-3-methyl-6-nitroaniline (CAS 1261676-68-9)
- 2-Chloro-3-methoxy-4-methylpyridine (CAS 1227562-13-1)
- 2-(4-(Difluoromethyl)-6-(4-fluorophenyl)-3-methyl-1h-pyrazolo[3,4-b]pyridin-1-yl)acetic acid (CAS 937607-14-2)
- 3-(5-Ethoxycarbonyl-2-furanyl)-1-propene (CAS 252357-14-5)
- 4-((3-Chloropyrazin-2-yl)amino)cyclohexan-1-ol (CAS 1250035-48-3)
- 2,3-Dimercaptopropane-1-sulfonic acid (CAS 74-61-3)
- 3,3,3-Trifluoro-N-(4-oxo-5,6,7,8-tetrahydro-4H-thiazolo[5,4-c]azepin-2-yl)propanamide (CAS 1797160-60-1)
- 98035-79-1 Small cardioactive peptide A L-Methioninamide, L-alanyl-L-arginyl-L-prolylglycyl-L-tyrosyl-L-leucyl-L-alanyl-L-phenylalanyl-L-prolyl-L-arginyl- SCPA (CAS 98035-79-1)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com